Akums Drugs and Pharmaceuticals signs framework agreement with Govt. of Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
The company has improved access to quality healthcare for seniors across both urban and rural areas
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
According to IQVIA sales data for the 12-month period ending June 2025, the Mycamine for Injection, 50 mg/vial and 100 mg/vial market achieved annual sales of approximately $60.7 million
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The projected business potential is around US$ 1 million in the first year
Subscribe To Our Newsletter & Stay Updated